Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer

The current staging method is inadequate to identify high-risk recurrence patients with stage II colon cancer (CC). Using a systematic and comprehensive-biomarker discovery and validation method, we aimed to construct a lncRNA-based signature to improve the prognostic prediction of stage II CC. We i...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Ailin, Wang, Qian, Chang, Qing, Liu, Jingkang, Yang, Yongmei, Zhang, Xin, Zhang, Yanli, Zhang, Xiaoshi, Wang, Hongchun, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873786/
https://www.ncbi.nlm.nih.gov/pubmed/36693876
http://dx.doi.org/10.1038/s41598-022-25852-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873786/
https://www.ncbi.nlm.nih.gov/pubmed/36693876
http://dx.doi.org/10.1038/s41598-022-25852-5

Ejemplares similares